MTB Antibiogram (TB NGS) by Next Generation Sequencing - Pure Culture

The MTB Antibiogram (TB NGS) by Next Generation Sequencing – Pure Culture test is an advanced molecular diagnostic test used to identify Mycobacterium tuberculosis (MTB) and analyze its resistance to anti-tuberculosis (TB) medications. The test is performed on a pure culture of the tuberculosis bacteria using Next Generation Sequencing (NGS) technology, which detects genetic mutations associated with drug resistance. This helps doctors determine the most effective treatment regimen for patients with tuberculosis, particularly those with suspected multidrug-resistant TB (MDR-TB).

The test is recommended for patients with confirmed tuberculosis, persistent TB symptoms despite treatment, or suspected drug-resistant TB. It can be performed on specimens such as sputum, bronchoalveolar lavage (BAL) fluid, cerebrospinal fluid (CSF), body fluids, aspirates, pus, or fresh tissue biopsies, depending on the site of infection. The MTB Antibiogram (TB NGS) test provides comprehensive information about drug susceptibility, enabling personalized treatment, improving patient outcomes, and helping prevent the spread of drug-resistant tuberculosis.